Tea Catechins in Green Tea Inhibit the Activity of SARS-CoV-2 Main Protease via Covalent Adduction.

Publication date: Feb 05, 2025

We herein examined the inhibitory effects of tea catechins on the SARS-CoV-2 main protease (M). Among the catechins analyzed, epigallocatechin 3-(3″-O-methyl)gallate, epigallocatechin gallate (EGCG), gallocatechin, gallocatechin gallate, and epigallocatechin inhibited recombinant M in a dose-dependent manner. Peptide mapping revealed that catechins preferentially formed covalent bonds with five sequences with the strongest activity at the C145 active site. Fragmentation analysis indicated 184 cleavages from peptides containing C145, corresponding to the D ring, suggesting that the B ring was attached to C145. When 10 bottled teas were incubated with M, four green teas inhibited the enzyme by over 80%, whereas the blended and barley teas showed no effect. EGCG reacted covalently with SARS-CoV-2 M within cells when incubated with cultured cells expressing M. This is the first study to report direct covalent binding between tea catechins and M in cells. This suggests that catechins from green tea can inhibit M in infected cells.

Concepts Keywords
Barley catechins
C145 coronavirus main protease
Green green tea
Inhibitory intracellular reaction
Tea pyrogallol

Semantics

Type Source Name
drug DRUGBANK Green tea leaf
drug DRUGBANK Epigallocatechin
drug DRUGBANK Epigallocatechin gallate
disease IDO site

Original Article

(Visited 2 times, 1 visits today)